The presence of anti-cardiolipin IgG antibodies originally poses a risk of arteriovenous thrombosis, but this combined with a decrease in protein S activity appears to have resulted in a chronic tendency to form thromboses due to a decreased ability to inhibit coagulation. The gene discussed is PROS1; the disease is deep vein thrombosis.